dapsone has been researched along with Cancer of Lung in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morris, LM | 1 |
| Lewis, HA | 1 |
| Cornelius, LA | 1 |
| Chen, DY | 1 |
| Rosman, IS | 1 |
| Beshay, A | 1 |
| Petersen, M | 1 |
| Rhoads, JLW | 1 |
| Zhao, CY | 1 |
| Liu, RC | 1 |
| Consuegra, G | 1 |
| Hui, R | 1 |
| Fernandez-Penas, P | 1 |
| Philip, PA | 1 |
| Fitzgerald, DL | 1 |
| Cartwright, RA | 1 |
| Peake, MD | 1 |
| Rogers, HJ | 1 |
| Reinert-Dilthey, I | 1 |
5 other studies available for dapsone and Cancer of Lung
| Article | Year |
|---|---|
Neutrophil-predominant bullous pemphigoid induced by checkpoint inhibitors: A case series.
Topics: Aged; Antimalarials; Dapsone; Drug Eruptions; Drug Therapy, Combination; Glucocorticoids; Humans; Im | 2020 |
Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
Topics: Acneiform Eruptions; Afatinib; Aged; Carcinoma, Non-Small-Cell Lung; Dapsone; Drug Eruptions; ErbB R | 2021 |
Epidermal growth factor receptor inhibitor-induced papulopustular eruption successfully treated with low-dose oral dapsone.
Topics: Administration, Oral; Carcinoma, Non-Small-Cell Lung; Dapsone; Dose-Response Relationship, Drug; Dru | 2018 |
Polymorphic N-acetylation capacity in lung cancer.
Topics: Acetylation; Adult; Aged; Aged, 80 and over; Dapsone; Female; Humans; Lung Neoplasms; Male; Middle A | 1988 |
[Duhring's dermatitis herpetiformis in lung cancer. Case report on a paraneoblastic skin disease].
Topics: Aged; Dapsone; Dermatitis Herpetiformis; Humans; Lung Neoplasms; Male; Skin Manifestations | 1970 |